Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
<p>HIV-1 has claimed the lives of millions of people globally and continues to spread despite development of highly active antiretroviral therapy. In 2013, 2.1 million new infections occurred and over 35 million people were living with HIV-1 infection. A prophylactic HIV-1 vaccine that can pre...
| Huvudupphovsmän: | , |
|---|---|
| Övriga upphovsmän: | |
| Materialtyp: | Lärdomsprov |
| Språk: | English |
| Publicerad: |
2014
|
| Ämnen: |